New 'Artificial Pancreas' aims to automate blood sugar control
NCT ID NCT05669547
Summary
This 12-month study tested a new automated system that delivers both insulin and glucagon to manage type 1 diabetes. It involved 243 adults in the Netherlands and compared this dual-hormone system to their current standard or advanced care. The main goal was to see if the new system could keep blood sugar in a healthy range more effectively over a long period.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Amsterdam UMC, AMC
Amsterdam, Netherlands
-
Amsterdam UMC, VUmc
Amsterdam, Netherlands
-
Catharina Ziekenhuis
Eindhoven, Netherlands
-
Gelre Ziekenhuis
Apeldoorn, Netherlands
-
Isala Klinieken
Zwolle, Netherlands
-
LUMC
Leiden, Netherlands
-
Martini Ziekenhuis
Groningen, Netherlands
-
Meander MC
Amersfoort, Netherlands
-
OLVG
Amsterdam, Netherlands
-
Rijnstate
Arnhem, Netherlands
-
St. Antonius
Nieuwegein, Netherlands
-
Tergooi Ziekenhuis
Hilversum, Netherlands
-
UMC Groningen
Groningen, Netherlands
-
UMC Utrecht
Utrecht, Netherlands
Conditions
Explore the condition pages connected to this study.